Pfizer Decision To Turn Off Temperature Sensors Forced Scramble To Ensure Covid-19 Vaccines Kept Ultra-Cold-STAT

Alast-minute snafu this fall threatened to disrupt the smooth rollout of the first Covid-19 vaccine approved in the United States, according to industry officials. At issue was how to monitor the temperature of the ultra-cold storage containers being used to distribute vials of the vaccine developed by Pfizer and its partner BioNTech. Pfizer, the officials told STAT, planned to disconnect temperature-monitoring sensors on the containers once they were delivered to health care providers — though many of the providers needed to use the boxes to store the vials for up to 30 days. STAT, 12/17/2020

•   Print
•   Email
•   Share
•   Tweet